April 26, 2018 / 5:12 AM / in 7 months

BRIEF-Xvivo Perfusion Q1 Adjusted. EBITDA Sek 7.2 Million

April 26 (Reuters) - Xvivo Perfusion AB:

* Q1 ADJUSTED. EBITDA SEK 7.2 MILLION VERSUS SEK 5.0 MILLION YEAR AGO

* Q1 NET SALES SEK 42.5 MILLION VERSUS SEK 37.5 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below